A unique asymmetric Schiff base compound originated from thenil underwent synthesis and characterization via analytical and spectroscopic methods. The compound was obtained through thenil (Di-2-thienylethanedione) and 1, 2-diaminotoluene reaction using standard synthetic procedures in various solvents. The compound displayed an asymmetric structure and was devoid of all symmetry elements. Antibacterial activity of the synthesized compounds was performed by it’s biological efficacy against S. aureus and S. typhi in-vitro agar-well diffusion testing as compared to doxycycline. The prepared compound exhibited potential as a superior antimicrobial drug candidate, although further scrutiny and evaluation as opposed to other trademark compounds remains a necessary step to evaluate the real potential of the molecule as a potential therapeutics against a variety of infectious diseases.
Preparing a monomeric [MoO2(SL)] containing a Schiff base was achieved by condensing furil with 3-bromo-5-(trifluoromethyl) benzene-1,2-diamine, along with preparing 4 different compounds containing [MoO2(MSL). A study of the interaction between 1,3-diketones and [MoO2(SL)] is presented in this paper. As part of the study, UV-Vis, magnetic, IR, NMR, and thermal characterization were carried out on five MoO2(VI) compounds. The coordination number of Mo will be six. The molybdenum octahedral geometry in these compounds consists of 4 N- and 2 O-atoms. When tested against S. aureus and S. typhi, there was moderate activity in all compounds synthesized. It is based on the chelation hypothesis that antibacterial tasks progress.